Baruch Ben Dor
Chief Executive Officer & Board Member
Dr. Ben Dor holds a Ph.D. in physics and is a graduate of the highly prestigious Talpiot program of the Israeli Air Force. His experience in the electro optics field dates to 1988, in both the defense sector and in the medical device industry. Dr. Ben Dor was previously the general manager of a startup company (Medibell Medical Vision Technologies Ltd.) in the field of ophthalmic digital photography leading it through finishing of prototype R&D, beta testing, production setup, and sales and marketing network development.
Prior to Medibell Dr. Ben Dor served as the director of marketing in Medibell’s mother company, CMT Medical (OEM producer of digital X-ray for Toshiba Medical). Dr. Ben Dor gained his international marketing experience as the vascular program director in the marketing department of ESC/Sharplan, an Israeli-based, global leader in the field of medical lasers, responsible for a worldwide network of reference sites for sales support, conducting clinical studies, and producing successful marketing campaigns.
Nancy Jean Barnabei
Chief Financial Officer
Ms. Barnabei has over 22 years of finance and accounting experience with both public and private companies in the biotechnology industry. She has served in senior financial positions with several emerging companies in which she played a key role in fundraising and the transition to executing growth strategies. Most recently, Ms. Barnabei served as VP Finance for GenSpera, Inc., where she was responsible for financial and administrative matters, SEC reporting, and fundraising activities.
Previously, Ms. Barnabei served as Chief Financial Officer of Immune Control, Inc. and its successor company, Corridor Pharmaceuticals, Inc., a drug development company. She founded Talkeetna Advisors, LLC in 2005, a consulting and advisory firm specializing in biotechnology companies, where she provided guidance on a variety of matters including strategic planning, budgeting, accounting, cash flow management, equity compensation, employee benefits, and raising of capital. From 2000 − 2004, she was Vice President Finance, Treasurer and Chief Financial Officer at Locus Pharmaceuticals, Inc. Her previous experience includes eight years at Cephalon, Inc., concluding as Corporate Controller. Ms. Barnabei earned a BS in business administration from Northeastern University, Boston, and is a certified public accountant.
Vice President of Sales and Marketing
Ms. McDonald has worked in the field of medical device sales and sales management for 30 years. During that time she has played a key role in several medical device start-up companies. In 1992, Ms. McDonald was hired at Pyxis Corporation as one of the early stage sales associates. Pyxis Corporation went on to reengineer medication distribution in the acute care market and was eventually sold to Cardinal Health for $980 million in 1995.
Following Pyxis, Ms. McDonald joined Aspect Medical Systems and held roles of increasing responsibility over her 12-year tenure. Ms. McDonald’s final position at Aspect was Vice President of Corporate Accounts. She managed OEM product launches with GE Medical, Philips Healthcare, and other patient monitoring companies. Aspect was successful in changing the way anesthesia providers manage medication delivery during surgery. Aspect Medical was acquired by Covidien in 2009. Most recently, Ms. McDonald was Vice President of Sales at Cheetah Medical, Inc. the inventors of a non-invasive hemodynamic monitor. At Cheetah, she was responsible for the US commercial efforts including the launch of a dedicated US sales team and defining market strategy. Ms. McDonald holds a Business degree from Western Michigan University.
Yosef Ben Dor
Vice President of International Sales
Mr. Ben Dor holds an MBA from INSEAD, and has extensive international experience as a former diplomat who speaks 5 languages and has lived and worked in Asia and Europe for many years. Mr. Ben Dor has a proven record in sales and distribution channel management and significant understanding and experience in building strategic relations with large multinational firms. In his recent position as the director of sales in Russia for Kodak Graphic Arts he grew annual sales from €12M to €60M within 3 years.
David L. Solt
Vice President for Research and Development
Mr. Solt is an electrical engineer who has specialized in electronic equipment development since 1976. His primary area of expertise has been in medical electronic devices development with the balance in military and commercial communications.
Prior to joining InfraScan, Inc., Mr. Solt was the VP of Manufacturing and R&D with Valley Forge Scientific Corp., directing the research team and leading the manufacturing team. Before that, Mr. Solt founded Omnitronix, a solid state AM broadcast transmitter manufacturer. Mr. Solt holds a Master’s Degree in Business Administration and a Master’s Degree in Engineering.
Executive Chair of the Board
Mr. Cohen has over thirty years of experience as a senior executive in the medical technology industry, compiling a successful track record in growing young companies and corporate operating divisions. Mr. Cohen has been an Operating Executive with SFW Capital Partners, a private equity firm, since 2009.
Previously, he was the President and Chief Executive Officer at CardioNet, a leading wireless medical technology company focused on remote diagnosis and monitoring of cardiac arrhythmias. Mr. Cohen led CardioNet to a successful IPO and secondary offering in 2008. Before joining CardioNet, Mr. Cohen was the Group President at Viasys Healthcare. He led the $450 million Respiratory Care Group overseeing 1200 employees in various locations around the globe. Viasys Healthcare was acquired in 2007 by Cardinal Health for $1.5 billion. Previously, he held executive positions with Respironics, Datascope, and Air-Shields. Mr. Cohen holds a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering from the University of California, Los Angeles.
Prof. Banu Onaral
Dr. Onaral is H. H. Sun Professor of Biomedical Engineering and Electrical Engineering at Drexel University. She holds a Ph.D. in Biomedical Engineering from the University of Pennsylvania and BSEE and MSEE in Electrical Engineering from Bogazici University, Istanbul, Turkey. Dr. Onaral joined the faculty of the Electrical and Computer Engineering Department and the Biomedical Engineering and Science Institute in 1981. She has served as the founding Director of the School of Biomedical Engineering Science and Health Systems since 1997. Dr. Onaral’s academic focus in both research and teaching is centered on signals and systems engineering with special emphasis on biomedical signal processing.
She has led major research and development projects sponsored by the National Science Foundation (NSF), National Institutes of Health (NIH), Office of Naval Research (ONR), DARPA, and Department of Homeland Security (DHS). She supervised many graduate students and has an extensive publication record in biomedical signals and systems. She is the recipient of a number of faculty excellence awards including the 1990 Lindback Distinguished Teaching Award of Drexel University, the EDUCOM Best Educational Software award and the NSF Faculty Achievement Award. Dr. Onaral’s professional services include chair and membership on advisory boards and strategic planning bodies of several universities and funding agencies, including service on the National Science Foundation’s Engineering Advisory Board, and on the proposal review panels and study sections.
Her editorial responsibilities have included service on the editorial board of journals and the CRC Biomedical Engineering Handbook as Section Editor for Biomedical Signal Analysis. She served as the President of the IEEE Engineering in Medicine and Biology Society (EMBS), the largest member-based biomedical engineering society in the world. Earlier, she had organized and chaired the 1990 Annual International Conference of the EMBS and served as the Co-Chair of the 2004 Annual Conference of the Biomedical Engineering Society. She has been a member of the inaugural Board of the American Institute for Medical and Biological Engineering. She is a Founding Fellow of the American Institute for Medical and Biological Engineering and a Fellow of the IEEE and the AAAS.
Mr. Chance is President of Non-Invasive Technology, Inc., a private company that licenses fundamental patents to the diagnostic, non-invasive medical device area. Previously, using his background in artificial intelligence, he began work at Unimation, at the time the nation’s largest and oldest industrial robot manufacturer. Mr. Chance left Unimation with Mr. Weiss, an MIT graduate, to start their own robot manufacturing company, U.S. Robots. After producing its first and second generation assembly robots, the Maker 100 and 200 series, they sold the company to Square D Company, an electrical equipment manufacturer.
Mr. Chance is a proponent of technology, innovation, and change, with a particular interest in the potential of artificial intelligence on the future. Mr. Chance belongs to a five-generation University of Pennsylvania family – he is the son of Dr. Britton Chance, an internationally known scholar and Professor Emeritus in Biochemistry/Biophysics, and nephew of Henry Chance II, a Penn Trustee and President of United Engineers, a family business founded by his grandfather, Edwin M. Chance, himself a graduate in civil engineering at Penn.
Dr. Shahram Hejazi is a life science investor/entrepreneur with executive general management experience in early-stage ventures and large global companies. Over his 20+ year career, Shahram has founded and/or directed the growth of more than a dozen startup companies. Since 2009, he has been a Venture Partner with BioAdvance, where he leads investments in devices, diagnostics, research tools and health IT. At BioAdvance he is a Board Director of Infrascan Inc., Optofluidics Inc., Enzium Inc., WellTrackOne Inc., HealthQX LLC (Observer), and Leversense LLC. In addition to his Board responsibilities at BioAdvance, Shahram is also on the Boards of SibTech Inc., and Integral Molecular Inc. Shahram is currently the 2014/2015 James Wei Visiting Professor of Entrepreneurship at Princeton University, teaching a senior/graduate level course on entrepreneurship and venture capital.
Prior to these, (2004-2008), Shahram was the President of Kodak’s Molecular Imaging division – where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service of three diverse business lines – and eventually selling it to a private equity firm. Before Kodak, (2001-2004) he was the founding CEO of Zargis Medical Corp. (a Siemens spinoff ) where he led the company from raising capital and the technology development to completion of several clinical trials, successful FDA regulatory approval and product launch – the company was later sold to 3M. Prior to Zargis, (1996-2001) Shahram was the Global Head of the Strategic Business Development at Siemens medical, responsible for identifying early stage growth/investment opportunities and new business development.
Earlier in his career, Shahram held R&D management positions at Kodak (Rochester) and IBM (Yorktown Heights). His past Board responsibilities includes FDA Industry Advisory Panel Member for Molecular and Clinical Genetic Devices, Fox Chase Cancer Center, Bioscan Inc., Alpha Innotech Corp. Shahram also serves on several university venture panels, and a speaker at many entrepreneurship events. Shahram has a PhD in electrical engineering with emphasis in biophysics (SUNY at Buffalo) and an executive business education (Stanford University).